The companies noted that, at 48 weeks, the novel investigational combination maintained a high rate (n=49; 94.2%) of viral ...

Improving HIV Treatment in Children and Adolescents -- The Right Way July 18, 2024 — Globally, around 2.6 million children and adolescents are currently living with HIV, the majority of them in ...

The Biden-Harris administration has a historic opportunity to help end HIV. New, cutting-edge drugs that prevent HIV are ...

Alchemy, a developer of in-house pharmacy programs for clinics with large HIV and hepatitis C patient populations, raised $31 ...

Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug ... Johns Hopkins University School of Medicine and Tufts University School ...

To bridge the gap until generic versions become available, Gilead has also committed to supply the product at no profit to ...

With advances in antiretroviral therapy, people living with HIV can expect to live longer and healthier than ever before if treatment is started at the time of diagnosis and taken as prescribed. With ...

The start of AIDS Awareness Month puts a spotlight on how treatment for HIV and AIDS has progressed over the past 40 years. Treatment for HIV/AIDS has consistently seen progress each decade ...

Lenacapavir is an important medication for HIV prevention and treatment. The agreement aims to bolster access to lenacapavir in 120 countries, with a particular focus on resource-limited nations that ...

Lenacapavir is approved by US FDA for infection caused by the human immunodeficiency virus (HIV) for heavily treatment-experienced patients (HTE), and is being investigated for use in HIV prevention.

Professor of medicine and deputy director of the Desmond Tutu HIV Centre at the Institute of Infectious Disease and Molecular Medicine, University of Cape Town A new drug to prevent HIV infection ...

Dr. Reddy’s has been granted a non-exclusive voluntary licence to manufacture Lenacapavir and market it in 120 countries, for the current approved indication of HIV treatment in heavily ...